Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease

International Journal of Impotence Research, Published online: 16 August 2019; doi:10.1038/s41443-019-0180-5Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease

Source: International Journal of Impotence Research - August 15, 2019 Category: Urology & Nephrology Authors: Peter Tsambarlis Laurence A. Levine Source Type: research